Yoon‐Jee Chae

423 total citations
48 papers, 311 citations indexed

About

Yoon‐Jee Chae is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yoon‐Jee Chae has authored 48 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yoon‐Jee Chae's work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Yoon‐Jee Chae is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Yoon‐Jee Chae collaborates with scholars based in South Korea, United States and India. Yoon‐Jee Chae's co-authors include Kyeong‐Ryoon Lee, Tae‐Sung Koo, Suk‐Jae Chung, Ji‐Eun Chang, Han‐Joo Maeng, Min‐Soo Kim, Kwang‐Hee Shin, Saeho Chong, Dae‐Duk Kim and Chang‐Koo Shim and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Journal of Pharmaceutical Sciences.

In The Last Decade

Yoon‐Jee Chae

44 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoon‐Jee Chae South Korea	11	90	74	41	39	32	48	311
Chintan Patel India	12	165 1.8×	56 0.8×	76 1.9×	18 0.5×	27 0.8×	47	380
Edyta Szałek Poland	12	114 1.3×	90 1.2×	38 0.9×	14 0.4×	93 2.9×	67	415
Nagarjun Rangaraj India	14	152 1.7×	48 0.6×	54 1.3×	78 2.0×	20 0.6×	18	599
Eugene Swenson United States	10	178 2.0×	121 1.6×	32 0.8×	9 0.2×	28 0.9×	19	1.0k
Eduardo Costa Pinto Brazil	16	93 1.0×	136 1.8×	103 2.5×	68 1.7×	28 0.9×	39	572
Xiaojian Dai China	10	104 1.2×	128 1.7×	87 2.1×	22 0.6×	73 2.3×	27	404
Carsten Schiller Switzerland	5	180 2.0×	107 1.4×	25 0.6×	23 0.6×	29 0.9×	9	799
Shilei Yang China	11	102 1.1×	69 0.9×	19 0.5×	27 0.7×	65 2.0×	23	329
Sara Carlert Sweden	6	78 0.9×	99 1.3×	16 0.4×	31 0.8×	16 0.5×	12	512
Ning Ou China	12	101 1.1×	39 0.5×	36 0.9×	17 0.4×	40 1.3×	31	348

Countries citing papers authored by Yoon‐Jee Chae

Since Specialization

Citations

This map shows the geographic impact of Yoon‐Jee Chae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon‐Jee Chae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon‐Jee Chae more than expected).

Fields of papers citing papers by Yoon‐Jee Chae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon‐Jee Chae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon‐Jee Chae. The network helps show where Yoon‐Jee Chae may publish in the future.

Co-authorship network of co-authors of Yoon‐Jee Chae

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon‐Jee Chae. A scholar is included among the top collaborators of Yoon‐Jee Chae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon‐Jee Chae. Yoon‐Jee Chae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Ji‐Eun, et al.. (2025). Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications. Pharmaceutics. 17(12). 1604–1604.

Jeong, Hyeon Cheol, et al.. (2025). Development and validation of an LC-MS/MS method for Tirzepatide, a dual GIP/GLP-1 receptor agonist, in rat plasma for application to a pharmacokinetic study. Journal of Chromatography B. 1268. 124836–124836.

Kang, Minji, Kyeong‐Ryoon Lee, You‐Jin Choi, & Yoon‐Jee Chae. (2024). Identification of flavonol derivatives inhibiting MDR1: a strategy to overcome multidrug resistance in cancer. Natural Product Research. 40(5). 1219–1227. 1 indexed citations

Lee, Kyeong‐Ryoon, et al.. (2024). Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management. Pharmaceutics. 16(11). 1431–1431. 2 indexed citations

Yoon, Hyejin, et al.. (2024). Enhanced anticancer efficacy of photodynamic therapy in combination with immunotherapy. Journal of Photochemistry and Photobiology B Biology. 261. 113048–113048. 1 indexed citations

Kang, Minji, et al.. (2024). Interactions of bosutinib with drug transporters: In vitro and In vivo inhibition of organic cation transporter 2, multidrug and toxin extrusion protein 1, and breast cancer resistance protein by bosutinib. Biomedicine & Pharmacotherapy. 178. 117114–117114. 1 indexed citations

Park, Minjung, et al.. (2024). Quality by design-based approach for the development of an analytical method for quantifying ponatinib in rat plasma. Heliyon. 10(19). e38637–e38637. 1 indexed citations

Lee, Kyeong‐Ryoon, et al.. (2024). Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions. Toxicology Letters. 394. 57–65. 1 indexed citations

Shin, Kwang‐Hee, Kyeong‐Ryoon Lee, Minji Kang, & Yoon‐Jee Chae. (2023). Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity. Chemico-Biological Interactions. 379. 110504–110504. 4 indexed citations

10.

Chae, Yoon‐Jee, et al.. (2023). Investigation of N-Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen. Pharmaceutics. 15(5). 1471–1471.

11.

Kim, Heejeong, et al.. (2023). Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)2D3-treated Caco-2 cells. European Journal of Pharmaceutical Sciences. 183. 106396–106396. 5 indexed citations

12.

Cho, Kwan Hyung, et al.. (2022). Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: Potential of its pharmacokinetic interactions in vivo. Biomedicine & Pharmacotherapy. 153. 113514–113514. 11 indexed citations

13.

Kim, Min‐Soo, et al.. (2022). Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans. Pharmaceuticals. 15(6). 709–709. 6 indexed citations

14.

Kim, Min‐Soo, et al.. (2021). Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans. Pharmaceutics. 13(6). 813–813. 16 indexed citations

15.

Kim, Tae‐Heon, Seungwon Lee, Hyun Jin Park, et al.. (2021). Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs. Journal of Chromatography B. 1179. 122862–122862. 18 indexed citations

16.

Chae, Yoon‐Jee, et al.. (2020). Development and validation of an LC-MS/MS method for monitoring larotrectinib, a tropomyosin-related kinase inhibitor, in mouse and human plasma and application to pharmacokinetic studies. Journal of Analytical Science & Technology. 11(1). 6 indexed citations

17.

Chae, Yoon‐Jee, Kyeong‐Ryoon Lee, Jong‐Hwa Lee, et al.. (2016). Feasibility of the functional expression of the human organic anion transporting polypeptide 1B1 (OATP1B1) and its genetic variant 521T/C in the mouse liver. European Journal of Pharmaceutical Sciences. 96. 28–36. 3 indexed citations

18.

Lee, Jong‐Hwa, Yoon‐Jee Chae, Kyeong‐Ryoon Lee, et al.. (2012). Development of a LC–MS method for quantification of FK-3000 and its application to in vivo pharmacokinetic study in drug development. Journal of Pharmaceutical and Biomedical Analysis. 70. 587–591. 5 indexed citations

19.

Lee, Kyeong‐Ryoon, Yoon‐Jee Chae, Jong‐Hwa Lee, et al.. (2012). QUANTIFICATION OF CILNIDIPINE IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY. Journal of Liquid Chromatography & Related Technologies. 35(2). 308–320. 14 indexed citations

20.

Lee, Kyeong‐Ryoon, et al.. (2011). A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application. Drug Development and Industrial Pharmacy. 37(12). 1394–1401. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact